Phase 3 Study With Ciprofloxacin Dispersion for Inhalation in Non-CF Bronchiectasis (ORBIT-3)

NCT01515007 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Cystic Fibrosis Bronchiectasis

Interventions

DRUG: Ciprofloxacin dispersion for inhalation
DRUG: Placebo

Sponsor

Aradigm Corporation

Collaborators

[object Object]